Swedish Orphan Biovitrum AB (publ) ( SOBI.ST) - Key Metrics
SOBI.ST Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q1 | ? | ? | ? | ? |
| 2025Q4 | SEK22.65 | SEK5.39 | SEK8.63 | SEK8.61 |
| 2025Q3 | SEK22.56 | -SEK8.40 | SEK5.34 | SEK5.32 |
| 2025Q2 | SEK17.96 | SEK1.85 | SEK4.21 | SEK2.99 |
| 2025Q1 | SEK18.82 | SEK2.55 | SEK6.68 | SEK6.65 |
SOBI.ST Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q1 | ? | ? |
| 2025Q4 | ? | 15.43 |
| 2025Q3 | ? | -8.54 |
| 2025Q2 | ? | 38.94 |
| 2025Q1 | ? | 28.20 |
SOBI.ST Free Cash Flow Yield and Dividend Yield
| Date | Free Cash Flow Yield | Dividend Yield |
|---|---|---|
| 2026Q1 | 0.64% | ? |
| 2025Q4 | 2.59% | ? |
| 2025Q3 | 1.85% | ? |
| 2025Q2 | 1.04% | ? |
| 2025Q1 | 2.31% | ? |
SOBI.ST
Price: SEK446.60
52 week price:
Earnings Per Share: 2.61 SEK
P/E Ratio: 165.44
Exchange: STO
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Market Capitalization: 149.9 billion